Bovatec® / MGA® 200

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 139876
  • Animal drug product ID 2749

What the source publishes

Holder
Phibro Animal Health Corp.
Active ingredients
Lasalocid Melengestrol Acetate
Form
Medicated Feed
Routes
Oral
Supply regime
OTC

Names this record is found by

Complete source data
us:fda:animaldrugs:1995:2749
{
  "form": "Medicated Feed",
  "name": "Bovatec® / MGA® 200",
  "holder": "Phibro Animal Health Corp.",
  "routes": [
    "Oral"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "OTC",
  "nativeProduct": {
    "routes": [
      "Oral"
    ],
    "species": {
      "Cattle:375": "Beef heifers"
    },
    "sortOrder": 0,
    "withdrawals": [],
    "doseFormName": "Medicated Feed",
    "applicationId": null,
    "specifications": "Please see NADA 140-288 for more information.",
    "proprietaryName": "Bovatec® / MGA® 200",
    "proprietaryNameId": 2749,
    "statusDescription": "OTC"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2026-08-11",
    "sponsorName": "Phibro Animal Health Corp.",
    "applicationId": 1995,
    "applicationType": "N",
    "proprietaryName": "Bovatec® / MGA® 200\nBovatec® / MGA® 100\n",
    "applicationNumber": 139876,
    "activeIngredientName": "Lasalocid\nMelengestrol Acetate\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "375",
      "label": "Cattle",
      "native": {
        "key": "Cattle:375",
        "population": "Beef heifers"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Beef heifers",
      "canonicalId": "cattle",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2026-08-11",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 1995,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Lasalocid\nMelengestrol Acetate\n",
  "nativeApplicationType": "N",
  "applicationIngredients": [
    {
      "activeIngredientName": "Lasalocid",
      "activeIngredientTolerance": "Tolerances for lasolocid residues are established as follows: \r\n\r\n      1.  Cattle:  The tolerance for parent lasalocid (the marker residue) in liver (the target tissue) is 0.7 part per million \r\n      2.  Chickens:  (I) Skin with adhering fat (the target tissue). The tolerance for parent lasalocid (the marker residue) is 1.2 parts per million.\r\n(ii) Liver. The tolerance for parent lasalocid (the marker residue) is 0.4 part per million. \r\n      3. Turkeys:   (I) Skin with adhering fat (the target tissue). The tolerance for parent lasalocid (the marker residue) is .4 part per million.\r\n(ii) Liver. The tolerance for parent lasalocid (the marker residue) is 0.4 part per million. \r\n       4.  Rabbits:  The tolerance for parent lasalocid (the marker residue) in liver (the target tissue) is 0.7 part per million.\r\n       5.  Sheep:  The tolerance for parent lasalocid (the marker residue) in liver (the target tissue) is 1.0 part per million"
    },
    {
      "activeIngredientName": "Melengestrol Acetate",
      "activeIngredientTolerance": "A tolerance of 25 parts per billion is established for residues of the parent compound, melengestrol acetate, in fat, of cattle."
    }
  ],
  "nativeApplicationNumber": 139876,
  "nativeProprietaryNameId": 2749,
  "restrictionObservations": [
    {
      "indicationText": "<p>Please see NADA 140-288 for more information.</p>",
      "limitationText": "<p>Please see NADA 140-288 for more information.</p>",
      "populationText": "Please see NADA 140-288 for more information."
    }
  ],
  "withdrawalPeriodsStatus": "not-reported",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:1995:2749"